Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to -$335000.0.

  • Sight Sciences' Change in Account Payables rose 4985.03% to -$335000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $427000.0, marking a year-over-year increase of 12419.26%. This contributed to the annual value of $336000.0 for FY2024, which is 13805.21% up from last year.
  • Sight Sciences' Change in Account Payables amounted to -$335000.0 in Q3 2025, which was up 4985.03% from -$688000.0 recorded in Q2 2025.
  • Over the past 5 years, Sight Sciences' Change in Account Payables peaked at $1.5 million during Q4 2021, and registered a low of -$1.8 million during Q3 2021.
  • Its 5-year average for Change in Account Payables is -$1210.5, with a median of $256000.0 in 2024.
  • In the last 5 years, Sight Sciences' Change in Account Payables soared by 45403.23% in 2023 and then tumbled by 36875.0% in 2025.
  • Over the past 5 years, Sight Sciences' Change in Account Payables (Quarter) stood at $1.5 million in 2021, then plummeted by 141.49% to -$617000.0 in 2022, then crashed by 179.42% to -$1.7 million in 2023, then skyrocketed by 121.87% to $377000.0 in 2024, then tumbled by 188.86% to -$335000.0 in 2025.
  • Its Change in Account Payables was -$335000.0 in Q3 2025, compared to -$688000.0 in Q2 2025 and $1.1 million in Q1 2025.